Compound Inheritance ID'd in Cases of Congenital Scoliosis

This article originally appeared here.
Share this content:
Compound Inheritance ID'd in Cases of Congenital Scoliosis
Compound Inheritance ID'd in Cases of Congenital Scoliosis

WEDNESDAY, Jan. 7, 2015 (HealthDay News) -- In a case series of Han Chinese persons, compound inheritance of a rare null mutation and a hypomorphic allele accounted for a proportion of congenital scoliosis cases. These findings were published online Jan. 7 in the New England Journal of Medicine.

Nan Wu, M.D., from the Peking Union Medical College Hospital in China, and colleagues used comparative genomic hybridization, quantitative polymerase-chain-reaction analysis, and DNA sequencing to assess 161 Han Chinese persons with sporadic congenital scoliosis, 166 Han Chinese controls, and two pedigrees, whose family members had a 16p11.2 deletion. Tests of replication were conducted in 76 Han Chinese persons with congenital scoliosis and a multicenter series of 42 people with 16p11.2 deletions.

The researchers identified heterozygous TBX6 null mutations in 11 percent of the 161 persons with sporadic congenital scoliosis; null mutations in TBX6 were not observed in the controls. The null alleles included copy-number variants and single-nucleotide variants. In all 17 carriers of TXB6 null mutations, the researchers identified a common TBX6 haplotype as the second risk allele. This compound inheritance model was confirmed in replication studies involving additional persons with congenital scoliosis who carried a deletion affecting TBX6. The risk haplotype was suggested to be a hypomorphic allele in in-vitro functional assays.

"Compound inheritance of a rare null mutation and a hypomorphic allele of TBX6 accounted for up to 11 percent of congenital scoliosis cases in the series that we analyzed," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »